Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
We are advising Roche on the acquisition
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
MSCI acquisition of Trove Research
We are advising MSCI on the acquisition
Instant Brands sale of substantially all of its assets to Centre Lane Partners
We are advising Instant Brands on the sale
AUO €600 million acquisition of BHTC
We are advising AUO on the acquisition
Qatar Investment Authority investment in Reliance Industries’ Reliance Retail Ventures
We are advising Reliance on the transaction
Abcam $5.7 billion acquisition by Danaher
We advised financial advisers to Abcam on the transaction
Chindata Group going-private transaction
We are advising APG on the transaction
Immedica Pharma acquisition of pegzilarginase assets from Aeglea
We advised Immedica on the transaction
Centogene strategic collaboration with Lifera
We are advising Centogene on its joint venture with and convertible debt investment by Lifera
Cadeler $597 million combination with Eneti
We are advising Cadeler on the transaction